久久伊人色AV天堂九九小黄鸭,亚洲精品久久久无码

利格列汀雜質(zhì) 利拉利汀雜質(zhì)?? 產(chǎn)品介紹：
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實驗研發(fā)，藥品申報檢測，不得用于臨床醫(yī)學診斷。
隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。

國產(chǎn)進口品牌皆有銷售，產(chǎn)品庫時常更新，部分雜質(zhì)長期備有庫存，可當天發(fā)貨，另外，我司有專業(yè)研發(fā)團隊，可提供雜質(zhì)定制服務，以zui大可能的滿足您對雜質(zhì)對照品的選購需求。

利格列汀雜質(zhì) 利拉利汀雜質(zhì)?? 雜質(zhì)列表：

Linagliptin	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1	7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 2	2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3	(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4	(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5	N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6	(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 7	8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 9	8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10	(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11	(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 12	8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13	(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14	(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15	(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17	(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 18	7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19	N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20	(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21	(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22	(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24	(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25	(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

?? 我司主營醫(yī)藥標準品及雜質(zhì)對照品，以下雜質(zhì)備有庫存，可當天發(fā)貨，*：依魯替尼雜質(zhì)，奧貝膽酸雜質(zhì)，依美斯汀雜質(zhì)，卡格列凈雜質(zhì)，利格列汀雜質(zhì)，西格列汀雜質(zhì)，埃索美拉唑雜質(zhì)，LCZ696雜質(zhì)，恩雜魯胺雜質(zhì)，艾曲波帕雜質(zhì)，非布司他雜質(zhì)，托匹司他雜質(zhì)，樂伐替尼雜質(zhì)，奧拉帕尼雜質(zhì)，阿維巴坦雜質(zhì)，奧美拉唑雜質(zhì)，普卡必利雜質(zhì)，西他沙星雜質(zhì)，泊沙康唑雜質(zhì)，替格瑞洛雜質(zhì)，托法替尼雜質(zhì)，決奈達隆雜質(zhì)，阿奇霉素雜質(zhì)等。

?? 美國劍橋CIL標準品部分產(chǎn)品列表：

DLM-277-PK HEXANOIC ACID (D11, 98%)

CLM-9146-0.01 5-ALPHA-DIHYDROTESTOSTERONE 97% CHEMICAL PURITY (2,3,4-13C3,99%)

EDF-4143-1 CALIBRATION CURVE, CDC1 DIOXIN, FURAN, & PCB IN TISSUE IN NONANE

JR-D45-25 1,2,4,6,7,9-HEXACDD UNLABELED ~25 NG/ML IN NONANE

CGM-1000-CN-20-S BIOEXPRESS CELL GROWTH MEDIA (U-13C, 19%; U-15N, 98%) (10X CONCENTRATE)

DLM-2084-PK L-DOPA (RING-D3, 98%)

H-922 ALPHA-HYDROXYMIDAZOLAM UNLABELED 1.0 MG/ML IN METHANOL

CRLM-4396-0 CHROMIUM-54 OXIDE (54Cr)

CLM-1896-PK INDOLE-3-ACETIC ACID (PHENYL-13C6, 99%)

H-049 HYDROMORPHONE (D6, 98%) 100 UG/ML IN METHANOL

EC-5000 WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 UNLABELED 2 UG/ML IN ISOOCTANE

CDLM-7754-PK SUCCINIC ACID (13C4, 99%; 2,2,3,3-D4, 98%)

DLM-143-5X1 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL-D2 (D, 98%)

PCB-170-C 2,2',3,3',4,4',5-HEPTACB UNLABELED

CLM-3876-PK SODIUM OCTANOATE (1,2,3,4-13C4, 99%)

CNLM-6696-PK CELL FREE AMINO ACID MIX (20 AA) (U-13C, 97-99%+; U-15N, 97-99%)

ES-5038-1-10X-1 CLP VOLATILES NON-KETONE DMC 10X STOCK SOLUTION 1000 UG/ML IN METHANOL-OD

EC-1436-1.2 2,2',3,4,4',5'-HEXACB (PCB-138) (13C12, 99%) 40+/-2 UG/ML IN NONANE

CLM-2093-MPT-PK ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

DLM-10-PK DIMETHYL SULFOXIDE-D6 (D, 99.9%)

EDF-5429-CS8H TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS8H (UNLABELED/13C12, 99%)

CLM-156-MPT-PK SODIUM ACETATE (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

DLM-6196-1.2 METHYLPHOSPHONIC ACID (METHYL-D3, 98%) 100 UG/ML IN METHANOL

CLM-2456-PK D-XYLOSE (1,2-13C2, 99%)

PCB-166-C 2,3,4,4',5,6-HEXACB UNLABELED

CDLM-7582-SL-1 HIS-UBIQUITIN DC (13C, 98%; D, 98%) *DISCONTINUED*

ULM-9091-1.2 TRIPHENYL PHOSPHATE UNLABELED 1 MG/ML IN ACETONITRILE

DLM-4721-0.5 L-CYSTEINE-N-FMOC, S-TRITYL (3,3-D2, 98%)

更多關于 ?? 的產(chǎn)品信息，請我司獲取詳情~

性猛交XXXX乱大交派对,四虎影视WWW在线观看免费 ,137最大但人文艺术摄影,联系附近成熟妇女

利格列汀雜質(zhì) 利拉利汀雜質(zhì) 返回列表頁

化工儀器網(wǎng)

會員登錄

收藏該商鋪

提示